NYSE:CAH

Cardinal Health Inc (CAH)

216.11
+3.44 (1.62%)
as of Jun 10, 2026, 7:24:14 pm Market Open.
44 watching
0
Investor Insights
star iconJun 10, 2026, 12:00 am

This summary was created by AI, based on 2 opinions in the last 12 months.

Cardinal Health Inc (CAH-N) is viewed positively by experts, particularly due to its recent acquisition of a urology company, suggesting growth potential. Analysts point out that as one of the three major distributors in the healthcare sector, the company stands to benefit significantly from demographic trends, such as an aging population and increased prescription rates, which provide long-term growth drivers. Although the stock has seen a decline, partly attributed to the recent acquisition of Solaris, this has created what some view as a buying opportunity. With a low forward P/E ratio of 16 and consistent earnings growth projected at 13% EPS, the stock presents an attractive risk-reward scenario. Moreover, it offers a yield of 1.35%, enhancing its appeal for income-focused investors.

consensus icon
Consensus
Bullish
valuation icon
Valuation
Undervalued
review icon
Similar
McKesson,MCK
DON'T BUY
Return on equity has been very strong, but the businesses are changing. Prefers others in this sector.
PAST TOP PICK
(Was a top pick Jul 17/03. Down 11%.) The day after it was picked, the Company announced a decrease in their earnings so this pick was an error.
BUY
A pretty good buy right now.
TOP PICK
Competition is limited. Has revenue growth of 20%. Good price.
PAST TOP PICK
(Was a top pick on April 22/03. Down 1%.) Still likes.
TOP PICK
Thin margins, but very large volumes gives good earnings growth, probably in the high teens.
BUY ON WEAKNESS
1 out of 6 drugs sold goes through this company. Buy at $60 or below.
BUY
Should do well, but buy on weakness. At a good price now.
BUY
Benefiting from a trend in drug distribution. Prefers over Walgreen.
DON'T BUY
High quality company. Strong mngmnt. Valuation is too high now.
Showing 31 to 40 of 40 entries